Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) has announced that its board of directors will convene on 29 October 2026. The primary agenda is to review and approve the consolidated third-quarter results for the nine months ended 30 September 2026 and to authorize their publication.
The meeting notice, dated 16 October 2026, was signed by Chairman Yang Qiuhua. The current board comprises four executive directors, one non-executive director, one employee representative director and four independent non-executive directors.
No additional financial figures or operational updates were disclosed in the announcement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments